Form 4: Resolute Holdings Director Joseph DeAngelo Granted 5,603 Stock Options

Sentiment:

Insider Transaction Report


Joseph J. DeAngelo, a Director and 10% Owner of Resolute Holdings Management, Inc., was granted 5,603 stock options with an exercise price of $33.92, vesting over four years.

Summary

  • Joseph J. DeAngelo, identified as a Director and 10% Owner of Resolute Holdings Management, Inc. (RHLD), reported an acquisition of derivative securities.
  • On May 28, 2025, Mr. DeAngelo was granted 5,603 stock options (Right to Buy) with an exercise price of $33.92 per share.
  • These stock options will vest in equal annual installments of 25% each, beginning on May 28, 2026, and continuing on the first, second, and third anniversaries thereafter.
  • The expiration date for these stock options is May 28, 2035.
  • Following this transaction, Mr. DeAngelo directly beneficially owns 5,603 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The grant of stock options to a director is generally viewed positively as it aligns the interests of management with those of shareholders, incentivizing long-term growth and value creation. It's a standard compensation practice.

Positives

  • The grant of 5,603 stock options to a director and 10% owner aligns management's interests with shareholder value, incentivizing long-term performance.
  • The options have a 10-year expiration period, providing a substantial long-term incentive for the director.

Future Outlook

The grant of stock options indicates a long-term incentive for the director, aligning future performance with potential equity gains, but the filing itself does not provide a broader company outlook or forward-looking statements beyond the vesting schedule.

Industry Context

The grant of stock options to directors is a common practice across industries to incentivize long-term performance and align management interests with shareholder value, particularly in publicly traded companies. This type of compensation is a standard component of executive and director remuneration packages.

Comparison to Industry Standards

  • The grant of stock options as part of executive and director compensation packages is a standard practice in publicly traded companies, comparable to compensation structures seen in various sectors.
  • The vesting schedule of 25% annually over four years is a common industry standard for equity grants, designed to retain talent and incentivize sustained performance.
  • The 10-year expiration period for the options is also typical for long-term incentive plans in the market.

Stakeholder Impact

  • Shareholders: The grant of stock options aims to align the director's interests with shareholder value creation, potentially leading to improved long-term performance and strategic decisions.
  • Employees: While this specific grant is for a director, equity compensation generally serves to motivate key personnel and align their efforts with company success.

Next Steps

  • Future vesting of the granted stock options on May 28, 2026, and subsequent anniversaries for three additional years.
  • Potential exercise of stock options by Joseph J. DeAngelo at or after their vesting dates and prior to their expiration.

Key Dates

DateDescription
05/28/2025Date of earliest transaction (grant of stock options).
05/30/2025Date the Form 4 was filed.
05/28/2026Date of the first 25% vesting installment for the granted stock options.
05/28/2035Expiration date of the stock options.

Recommendation

hold

Keywords

Resolute Holdings Management, RHLD, Joseph J. DeAngelo, Stock Options, Insider Trading, SEC Form 4, Director Compensation, Equity Grant, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.